Evommune Inc (EVMN)

fmr.CEO Missling made 2 recent posts on Linkedin.

I'm sure it's just a coincidence these things began to happen shortly after F2 were made the only OTC issues available to trade through Robinhood 😜

$FMCC~ $FNMA~

At least the dilution stopped!

Look up a company that just had its IPO, Apotex (APTX). This site says cash flow value is $62.18 (same metric you are using for Elite’s $2.55). The IPO price was about $24. I don’t think the calculation for this metric is reliable or even close. For an IPO you are maximizing share price as the compa

Forget about the FDA for just a bit, once we have a cleanroom approved with EDEN's, then ask.
Actually, at that point you can also ask about Europe, Canada, Australia, etc. as they'll all potentially be targets for approvals.

I don't know how the company intends to build, numer

 I might need a little help to get this to the finish line. Just give me .29 so I can start reloading and then I will let it boom. It can’t be just me playing chicken with my shares. I take the risk while someone scoops in and buys the cheapies. Not fair. 

BORING !!  Come on guys, what’s going on?  Announce something ! 

Who’s going to help me get this to .20s next week! Let’s go!Big walls ‘a comin

2026 10th Capital Link Maritime Leaders Summit – Greece | Navigating the Market

https://youtu.be/CiPXZ7_tVJc

Wrong. 1/29/26 I’m on record:

“I’m happy to finally free up some cash and still hold a bag.”

Which is still true.

The part I embellished: price was .008 not .0085 🫡

If the system just "created" a new profile for her, then why does it say the profile was created back in 2025?

Because IHub hasn't yet updated that. Go to the Message List page and scroll up to "Search this Board". You'll see that the last year available for a search is 2025. But in r

You keep repeating "negative margins" as if businesses never improve economics over time. The awkward part is ignoring the obvious operational changes that affect cost structure.

The logic here seems to be: "it wasn't profitable before, therefore it can never be profitable." That's no

Supposedly HDUP acquired this "LotteryHUB" in May 2022, according to their disclosure. However:

1. HDUP still listing as "acquired in the last 12 months" even as of April 2026
2. Nothing on the website "lotteryhub.com" indicates any connection to: HDUP, Mark Hutchison, Kelly

Musk has literally guaranteed his employees a very handsome and maximum return with no chance of the stock cratering before they all dispose of what they wish to sell. SMART MOVE FOR HIM AND HIS EMPLOYEE'S . IMO they will be able to buy back in when it tanks for the first time. IT is not worth th

I understand now,merger was complete but had a 20 day mandatory conversion waiting period from filing date ,it ended Wednesday and merger was complete and new company’s first day was Thursday,Friday was 1st day of some institutional buying (burst basket trades) Monday could be really good with insti

Wow, we always suspected! Good link!

RockQQ

I came to the sad conclusion that discussing
RDHL is a sheer waste of time!
:-(

The short song and dance is over rockafella, You just can’t get em cheapies so easily.. You got to pay to play in the big leagues

Oh yes, I remember. It's a pretty color. And they're very useful.

I may not be able to resist. It really IS a fabulous value. The reviewers seem to like it.

2026 10th Capital Link Maritime Leaders Summit – Greece | Dry Bulk at an Inflection Point

https://youtu.be/adh3JnRr8qo

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

lol there was no waiver. Glad you are now caught up on the real timeline. 

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund